Gabather AB (publ) (STO:GABA)
Sweden · Delayed Price · Currency is SEK 0.0302
+0.0004 (1.34%)
Sep 11, 2026, 3:45 PM CET
Gabather AB Market Cap
Gabather AB has a market cap or net worth of 18.44 million as of September 11, 2026. Its market cap has increased by 95.14% in one year.
Market Cap
18.44M
Enterprise Value
14.75M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
ChartMarket Cap Chart
Since November 3, 2014, Gabather AB's market cap has decreased from 43.24M to 18.44M, a decrease of -57.36%. That is a compound annual growth rate of -6.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 18.44M | 64.34% |
| Dec 30, 2025 | 11.22M | 18.25% |
| Dec 30, 2024 | 9.49M | -54.20% |
| Dec 29, 2023 | 20.71M | -66.45% |
| Dec 30, 2022 | 61.73M | 1.64% |
| Dec 30, 2021 | 60.74M | -19.08% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nanexa AB | 1.09B |
| Dicot Pharma AB | 841.50M |
| EQL Pharma AB | 795.82M |
| Cinclus Pharma Holding AB | 588.24M |
| Moberg Pharma AB | 526.54M |
| Enzymatica AB | 521.88M |
| Orexo AB | 464.46M |
| Klaria Pharma Holding AB (publ.) | 152.01M |